CARREYROU

IN 2014, THERANOS FOUNDER AND CEO ELIZABETH HOLMES WAS WIDELY SEEN AS THE FEMALE STEVE JOBS: A BRILLIANT STANFORD DROPOUT WHOSE STARTUP “UNICORN” PROMISED TO REVOLUTIONIZE THE MEDICAL INDUSTRY WITH A MACHINE THAT WOULD MAKE BLOOD TESTING SIGNIFICANTLY FASTER AND EASIER. BACKED BY INVESTORS SUCH AS LARRY ELLISON AND TIM DRAPER, THERANOS SOLD SHARES IN A FUNDRAISING ROUND THAT VALUED THE COMPANY AT MORE THAN $9 BILLION, PUTTING HOLMES’S WORTH AT AN ESTIMATED $4.7 BILLION. THERE WAS JUST ONE PROBLEM: THE TECHNOLOGY DIDN’T WORK.